Calcitonin receptor mRNA in mononuclear leucocytes from postmenopausal women: Decrease during osteoporosis and link to bone markers with specific isoform involvement

Bone

Volumn 27, Issue 1, 2000, Pages 161-168

  Beaudreuil, J ^a   Taboulet, J ^a   Orcel, P ^a   Graulet, A M ^a   Denne, M A ^a   Baudoin, C ^a   Jullienne, A ^a   De Vernejoul, M C ^a  

^a CENTRE VIGGO PETERSEN   (France)

Author keywords

Bone markers; Bone resorption; Calcitonin receptor; Isoform; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCITONIN; CALCITONIN RECEPTOR; DEOXYPYRIDINOLINE; MESSENGER RNA; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; FEMALE; HUMAN; ISOMERISM; MAJOR CLINICAL STUDY; MONOCYTE; OSTEOCLAST; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BIOLOGICAL MARKERS; BONE AND BONES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PROTEIN ISOFORMS; RECEPTORS, CALCITONIN; RNA, MESSENGER;

EID: 0034080247     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00305-7     Document Type: Article

References (53)

1. Albrandt K., Brady E.M.G., Moore C.X., Mull E., Sierzega M.E., Beaumont K. Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene. Endocrinology. 136:1995;5377-5383.
2. Body J.J., Fernandez G., Lacroix M., Vandenbussche P., Content J. Regulation of lymphocyte calcitonin receptors by interleukin-1 and interleukin-6. Calcif Tissue Int. 55:1994;9-13.
3. Body J.J., Glibert F., Nejai S., Fernandez G., Van Langendonck A. Calcitonin receptors on circulating normal human lymphocytes. J Clin Endocrinol Metab. 71:1990;675-681.
4. Chambers T.J., Magnus C.J. Calcitonin alters behavior of isolated osteoclasts. J Pathol. 136:1982;27-39.
5. Chesnut C.H. III, Baylink D.J., Sisom K., Nelp W.B., Roos B.A. Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis. Metab Clin Exp. 29:1980;559-562.
6. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem. 162:1987;156-159.
7. Cohen-Solal M., Graulet A.M., Gueris J., Bergot C., Morieux C., Sedel L., Kuntz D., de Vernejoul M.C. Bone resorption at the femoral neck is dependent on local factors in non osteoporotic late postmenopausal woman. J Bone Miner Res. 10:1995;307-315.
8. Ebeling P.R., Atley L.M., Guthrie J.R., Burger H.G., Dennerstein L., Hopper J.L., Wark J.D. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 81:1996;3366-3371.
9. Findlay D.M., Houssami S., Christopoulos G., Sexton P.M. Homologous regulation of the rat C1a calcitonin receptor (CTR) in nonosteoclastic cells is independent of CTR messenger ribonucleic acid changes and cyclic adenosine 3′,5′-monophosphate-dependent protein kinase activation. Endocrinology. 137:1996;4576-4585.
10. Findlay D.M., Houssami S., Lin H.Y., Myers D.E., Brady C.L., Darcy P.K., Ikeda K., Martin T.J., Sexton P.M. Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity. Mol Endocrinol. 8:1994;1691-1700.
11. Findlay D.M., Michelangeli L.V.P., Martin T.J. Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line. J Endocrinol. 88:1981;271-281.
12. Fouchereau-Peron M., Moukhtar M.S., Benson A.A., Milhaud G. Characterization of specific receptors for calcitonin in porcine lung. Proc Natl Acad Sci USA. 78:1981;3973-3975.
13. Frendo J.L., Delage-Mourroux R., Cohen R., Pichaud F., Pidoux E., Guliana J.M., Jullienne A. Calcitonin receptor mRNA is expressed in human medullary thyroid carcinoma. Thyroid. 8:1998;1-7.
14. Frendo J.L., Pichaud F., DeLage-Mourroux R., Bouizar Z., Segond N., Moukthar M.S., Jullienne A. An isoform of the human calcitonin receptor is expressed in TT cells and in medullary carcinoma of the thyroid. FEBS Lett. 342:1994;214-216.
15. Garnero P., Shih W.J., Gineyts E., Karpf D.B., Delmas P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 79:1994;1693-1700.
16. Genant H.K., Wu C.Y., Van Kuijk C., Nevitt M.C. Vertebral fracture assessement using a semi quantitative technic. J Bone Miner Res. 8:1993;1137-1148.
17. Gorn A.H., Lin H.Y., Yamin M., Auron P.E., Flannery M.R., Tapp D.R., Manning C.A., Lodish H.F., Krane S.M., Goldring S.R. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest. 90:1992;1726-1735.
18. Gorn A.H., Rudolph S.M., Flannery M.R., Morton C.C., Weremowicz S., Wang J.T., Krane S.M., Goldring S.R. Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. J Clin Invest. 95:1995;2680-2691.
19. Kuestner R.E., Erold R.D., Grant F.J., Hagen F.S., Kuijper J.L., Matthewes S.L., O'Hara P.J., Sheppard P.O., Stroop S.D., Thompson D.L. Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol Pharmacol. 46:1994;246-255.
20. Kurokawa M., Michelangeli V.P., Findlay D.M. Induction of calcitonin receptor expression by glucocorticoids in T47D human breast cancer cells. J Endocrinol. 130:1991;321-326.
21. Kushida K., Takahashi M., Kawana K., Inoue T. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subject, and osteoporosis patients. J Clin Endocrinol Metab. 80:1995;2447-2450.
22. Lee S.K., Goldring S.R., Lorenzo J.A. Expression of the calcitonin receptor in bone marrow cell cultures and in bone a specific marker of the differentiated osteoclast that is regulated by calcitonin . Endocrinology. 136:1995;4572-4581.
23. Lin H.Y., Harris T.L., Flannery M.S., Aruffo A., Kaji H.E., Gorn A., Kolakowski L.F., Lodish H.F., Golding S.R. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science. 254:1991;1022-1024.
24. Marx S., Woodard C., Aurbach G. Calcitonin receptors of kidney and bone. Science. 172:1972;999-1000.
25. Marx S.J., Aurbach G.D., Gavin J.R., Buell D.W. Calcitonin receptors on cultured human lymphocytes. J Chem. 249:1974;6812-6816.
26. MBalaviele G., Jullienne A., de Vernejoul M.C. Human umbilical cord blood monocytes express calcitonin receptors in culture in the presence of 1,25 dihydroxyvitamin D. J Clin Endocrinol Metab. 72:1991;356-361.
27. Moore E.E., Kuestner R.E., Stroop S.D., Grant F.J., Matthewes S.L., Brady C.L., Sexton P.M., Findlay D.M. Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Mol Endocrinol. 9:1995;959-968.
28. Nakamura M., Hashimoto T., Nakajima T., Ichii S., Furuyama J.I., Ishihara Y., Kakudo K. A new type of human calcitonin receptor isoform generated by alternative splicing. Biochem Biophys Res Commun. 209:1995;744-751.
29. Nussenzveig D.R., Mathew S., Gershengorn M.C. Alternative splicing of a 48-nucleotide exon generates two isoforms of the human calcitonin receptor. Endocrinology. 136:1995;2047-2051.
30. Nussenzveig D.R., Thaw C.N., Gershengorn M.C. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes. J Biol Chem. 269:1994;28123-28129.
31. Overgaard K., Hansen M.A., Jensen S.B., Christiansen C. Effect of s-calcitonin given intranasally on bone mass and fracture rates in established osteoporosis a dose-response study . Br Med J. 305:1992;556-561.
32. Pacifici R., Basilico C., Roman J., Zutter M.M., Santoro S.A., McCracken R. Collagen-induced release of Interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding α5β1 Integrin. J Clin Invest. 89:1992;61-67.
33. Pacifici R., Carano A., Santoro S.A., Rifas L., Jeffrey J.J., Malone J.D., McCracken R., Avioli L.V. Bone matrix constituents stimulate Interleukin-1 release from human blood mononuclear cells. J Clin Invest. 87:1991;221-228.
34. Rakopoulos M., Ikegame M., Findlay D.M., Martin T.J., Moseley J.M. Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA. Bone. 17:1995;447-453.
35. Reginster J.Y. Calcitonin for prevention and treatment of osteoporosis. Am J Med. 95:(Suppl.):1993;44-47.
36. Reginster J.Y., Deroisy R., Albert A., Lecart M.P., Colette J., Franchimont P. Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics. J Clin Invest. 83:1989;1073-1077.
37. Schneider H.G., Raue F., Zink A., Koppold A., Ziegler R. Down-regulation of calcitonin receptors in T47D cells by internalization of calcitonin-receptor complexres. Mol Cell Endocrinol. 58:1988;9-15.
38. Seibel M.J., Cosman F., Shen V., Gordon S., Dempster D.W., Ratcliffe A., Lindsay R. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res. 8:1993;881-889.
39. Sexton P.M., Houssami S., Hilton J.M., O'Keeffe L.M., Center R.J., Gillespie M.T., Darcy P., Findlay D.M. Identification of brain isoforms of rat calcitonin receptor. Mol Endocrinol. 7:1993;815-821.
40. Stevenson J.C., Abeyasekara G., Hillyard C.J., Phang K.G., Macintyre I., Campbell S., Lane G., Townsend P.T., Young O., Whitehead M.I. Regulation of calcium-regulating hormone by exogenous sex steroids in early menopause. Eur J Clin Invest. 13:1983;481-487.
41. Su Y., Chakraborty M., Nathanson M.H., Baron R. Differential effects of the 3′,5′-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin. Endocrinology. 131:1992;1497-1502.
42. Suzuki K., Uchii M., Nozawa R. Expression of calcitonin receptors on human myeloid leukemia cells. J Biochem. 118:1995;448-452.
43. Taggart H.Mc.A., Ivey J. L.L., Sisom K., Chesnut C.H. III, Baylink D.J., Huber M.B. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis? Lancet. i:1982;475-478.
44. Takahashi N., Yamana H., Yoshiki S., Roodman G.D., Mundy G.R., Jones J.S., Boyde A., Suda T. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 122:1988;1373-1382.
45. Takahashi S., Goldring S., Katz M., Hilsenbeck S., Williams R., Roodman G.D. Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest. 95:1995;167-171.
46. Tiegs R.D., Body J.J., Wahner H.W., Barta J., Riggs B.L., Heath H. III. Calcitonin secretion in postmenopausal osteoporosis. N Engl J Med. 312:1985;1097-1100.
47. Uebelhart D., Schlemmer A., Johansen J.S., Gineyts E., Christiansen C., Delmas P. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab. 72:1991;367-373.
48. Wada S., Akatsu T., Tamura T., Takahashi N., Suda T., Nagata N. Glucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells. J Bone Miner Res. 9:1994;1705-1712.
49. Wada S., Martin T.J., Findlay D.M. Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Endocrinology. 136:1995;2611-2621.
50. Wada S., Udagawa N., Nagata N., Martin T.J., Findlay D.M. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase A-mediated mechanism. Endocrinology. 137:1996;312-320.
51. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., Sporn M.B. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA. 84:1987;5788-5792.
52. Warshawsky H., Goltzman D., Rouleau M.F., Bergeron J.J. Direct in vivo demonstration by autoradiography of specific binding sites for calcitonin in skeletal and renal tissues of the rat. J Cell Biol. 85:1980;682-694.
53. Zaidi M., Datta H.K., Moonga B.S., MacIntyre I. Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways. J Endocrinol. 126:1990;473-481.